http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102491445-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2023-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2023-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102491445-B1
titleOfInvention Method of manufacturing levocetirizine by optical resolution
abstract The present invention relates to a method for preparing levocetirizine by optical resolution, and includes (±)-2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy ) An optically active levocetirizine compound with high optical purity and high yield and a method for preparing the same can be provided by optical resolution by adding an optical resolving agent (R)-binol to acetic acid.
priorityDate 2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100503443-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416056123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425836335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415959281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22322686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID668697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422511954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449102014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID409810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944

Total number of triples: 52.